MA28535B1 - Utilisation de composes organiques - Google Patents
Utilisation de composes organiquesInfo
- Publication number
- MA28535B1 MA28535B1 MA29389A MA29389A MA28535B1 MA 28535 B1 MA28535 B1 MA 28535B1 MA 29389 A MA29389 A MA 29389A MA 29389 A MA29389 A MA 29389A MA 28535 B1 MA28535 B1 MA 28535B1
- Authority
- MA
- Morocco
- Prior art keywords
- organic compounds
- compounds
- organic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55387704P | 2004-03-17 | 2004-03-17 | |
US55735804P | 2004-03-29 | 2004-03-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28535B1 true MA28535B1 (fr) | 2007-04-03 |
Family
ID=34962409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29389A MA28535B1 (fr) | 2004-03-17 | 2006-10-13 | Utilisation de composes organiques |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080161321A1 (fr) |
EP (2) | EP1729749A2 (fr) |
JP (2) | JP2007529459A (fr) |
KR (1) | KR20070006774A (fr) |
AU (2) | AU2005224014B9 (fr) |
BR (1) | BRPI0508880A (fr) |
CA (1) | CA2558020A1 (fr) |
IL (2) | IL177831A0 (fr) |
MA (1) | MA28535B1 (fr) |
NO (1) | NO20064672L (fr) |
NZ (2) | NZ549535A (fr) |
RU (2) | RU2426532C2 (fr) |
SG (1) | SG153831A1 (fr) |
TW (1) | TW200605867A (fr) |
WO (1) | WO2005089731A2 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20060416A1 (es) * | 2004-08-03 | 2006-06-09 | Novartis Ag | Composicion de inhibidores de renina e inhibidores de proteinas de efusion |
ITMI20050150A1 (it) | 2005-02-03 | 2006-08-04 | Umberto Cornelli | Prodotti alimentari |
JP2009512715A (ja) * | 2005-10-21 | 2009-03-26 | ノバルティス アクチエンゲゼルシャフト | レニン阻害剤と抗異脂肪血症剤および/または抗肥満症剤の組み合わせ |
AU2007213069B2 (en) * | 2006-02-06 | 2010-12-23 | Novartis Ag | Combination of organic compounds |
ITMI20060384A1 (it) * | 2006-03-03 | 2007-09-04 | Umberto Cornelli | Composizioni comprendenti chitosano atte al trattamento terapeutico complessivo o alla prevenzione complessiva della sindrome metabolica |
FR2902009B1 (fr) * | 2006-06-13 | 2012-12-07 | Bioprojet Soc Civ | Utilisation d'un inhibiteur de vasopeptidase pour le traitement de l'hypertension arterielle pulmonaire |
BRPI0721167A2 (pt) * | 2006-12-15 | 2014-03-18 | Novartis Ag | Inibidores de renina para prevenção e tratamento de hipertensão em pacientes obesos. |
TWI452044B (zh) | 2007-06-15 | 2014-09-11 | Mitsubishi Tanabe Pharma Corp | 嗎啉衍生物 |
US20090054473A1 (en) * | 2007-08-22 | 2009-02-26 | Gilead Colorado, Inc. | Therapy for complications of diabetes |
JO3239B1 (ar) * | 2008-09-22 | 2018-03-08 | Novartis Ag | تركيبات جالينية من مركبات عضوية |
AR077428A1 (es) * | 2009-07-29 | 2011-08-24 | Sanofi Aventis | (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos |
AU2010305901A1 (en) | 2009-10-14 | 2012-05-24 | Rainer Oberbauer | Acute kidney injury risk testing |
WO2016019226A1 (fr) * | 2014-08-01 | 2016-02-04 | University Of Utah Research Foundation | Compositions et procédés d'utilisation d'antagonistes du récepteur de la (pro)rénine |
US9586995B2 (en) | 2012-09-19 | 2017-03-07 | University Of Utah Research Foundation | Compositions and methods of use for (pro)renin receptor |
US9573976B2 (en) | 2012-09-19 | 2017-02-21 | University Of Utah Research Foundation | Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes |
US10780143B2 (en) | 2012-09-19 | 2020-09-22 | University Of Utah Research Foundation | Compositions and methods of use for (pro)renin receptor antagonists |
JP6198047B2 (ja) * | 2013-08-02 | 2017-09-20 | 国立大学法人岐阜大学 | 冠動脈疾患の検査キット |
US20170014386A1 (en) * | 2015-07-16 | 2017-01-19 | Abbvie, Inc. | Treatment of Multidrug-Resistant Nephrotic Syndrome (MDR-NS) in Children |
MA44836A (fr) * | 2015-08-26 | 2018-07-04 | Univ Texas | Procédés de traitement du syndrome polykystique des reins |
JP6743129B2 (ja) * | 2016-03-18 | 2020-08-19 | テルモ株式会社 | 心機能測定装置、心機能測定方法および心機能測定プログラム |
KR20230174238A (ko) | 2021-04-21 | 2023-12-27 | 니혼 메디피직스 가부시키가이샤 | 방사성 항종양제 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1962497C3 (de) | 1969-12-12 | 1979-09-20 | C.H. Boehringer Sohn, 6507 Ingelheim | Naphthylalkyl- a -hydroxyphenäthyl-amine, ihre Herstellung und diese enthaltende Arzneimittel |
US3931305A (en) | 1973-08-20 | 1976-01-06 | Standard Oil Company | Terephthalic acid recovery by continuous flash crystallization |
US4889861A (en) | 1982-12-21 | 1989-12-26 | Ciba-Geigy Corp. | Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors |
US4617307A (en) | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
US4885292A (en) * | 1986-02-03 | 1989-12-05 | E. R. Squibb & Sons, Inc. | N-heterocyclic alcohol renin inhibitors |
CA1334092C (fr) | 1986-07-11 | 1995-01-24 | David John Carini | Imidazoles bloquant les recepteurs de l'angiotensine ii |
US5594021A (en) | 1993-05-20 | 1997-01-14 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin |
EP0955294B1 (fr) | 1989-06-14 | 2003-09-24 | Smithkline Beecham Corporation | Acides imidazoalcénoiques |
US5194605A (en) * | 1989-12-08 | 1993-03-16 | Merck & Co., Inc. | Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs |
US5182266A (en) * | 1990-01-31 | 1993-01-26 | Abbott Laboratories | Method for treating renal disease |
DE19675036I2 (de) | 1990-02-19 | 2004-10-21 | Novartis Ag | Acylverbindungen. |
NZ237476A (en) | 1990-03-20 | 1994-01-26 | Sanofi Sa | N-substituted heterocyclic compounds and pharmaceutical compositions. |
US5196444A (en) | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
US5821232A (en) * | 1990-05-11 | 1998-10-13 | Pfizer Inc. | Synergistic therapeutic compositions and methods |
JP3398379B2 (ja) * | 1990-12-14 | 2003-04-21 | スミスクライン・ビーチャム・コーポレイション | アンジオテンシンii受容体遮断組成物 |
IS1756B (is) | 1991-02-21 | 2000-12-28 | Sankyo Company Limited | Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða |
ZA921381B (en) * | 1991-03-01 | 1992-11-25 | Fujisawa Pharmaceutical Co | New use of amino acid derivatives |
RU2086544C1 (ru) | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
DE4121975A1 (de) | 1991-07-03 | 1993-01-07 | Basf Ag | Thermoplastische formmassen auf der basis von polycarbonaten, styrol/acrylnitril-polymerisaten und polyolefinen |
US5202322A (en) * | 1991-09-25 | 1993-04-13 | Merck & Co., Inc. | Quinazolinone and pyridopyrimidine a-II antagonists |
TW226375B (fr) | 1991-10-24 | 1994-07-11 | American Home Prod | |
US5376638A (en) * | 1992-09-01 | 1994-12-27 | Amylin Pharmaceuticals, Inc. | Methods for treating renin-related disorders with amylin antagonists |
ATE213156T1 (de) | 1993-04-27 | 2002-02-15 | Smithkline Beecham Corp | Endothelin-rezeptor-antagonisten |
US5508272A (en) | 1993-06-15 | 1996-04-16 | Bristol-Myers Squibb Company | Compounds containing a fused bicycle ring and processes therefor |
CN1049219C (zh) | 1993-08-18 | 2000-02-09 | 万有制药株式会社 | 具有内皮素拮抗活性的芳香杂环并环戊烯衍生物 |
MY119161A (en) | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
DE69527072T2 (de) | 1994-08-19 | 2003-02-13 | Abbott Lab | Endothelin antagoniste |
US5612359A (en) | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
DE19533023B4 (de) | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
TW313568B (fr) | 1994-12-20 | 1997-08-21 | Hoffmann La Roche | |
CZ292327B6 (cs) | 1995-09-07 | 2003-09-17 | F. Hoffmann-La Roche Ag | Derivát 4-(oxyalkoxyfenyl)-3-oxypiperidinu, způsob jeho přípravy, meziprodukt pro jeho přípravu a farmaceutický prostředek, který ho obsahuje |
RU2172735C2 (ru) | 1995-12-20 | 2001-08-27 | Яманоути Фармасьютикал Ко., Лтд. | Арилэтенсульфонамидные производные и фармацевтическая композиция |
IT1277737B1 (it) | 1995-12-28 | 1997-11-12 | Zambon Spa | Derivati tiolici ad attivita' inibitrice delle metallopeptidasi |
WO1997027314A1 (fr) | 1996-01-23 | 1997-07-31 | Shionogi & Co., Ltd. | Processus de production d'analogues d'acide oleanolique par la culture de racine pileuse |
JP3345891B2 (ja) | 1996-04-04 | 2002-11-18 | 萬有製薬株式会社 | エンドセリン拮抗薬を含有することを特徴とする心不全治療剤 |
SE9903028D0 (sv) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
DE60022525T2 (de) * | 1999-08-30 | 2006-06-14 | Sanofi Aventis Deutschland | Ramipril zur vorbeugung von kardiovaskulären vorfällen |
CA2420055C (fr) * | 2000-08-25 | 2010-06-01 | Takeda Chemical Industries, Ltd. | Agent de reduction du fibrinogene |
US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
EP1448190A2 (fr) * | 2001-10-18 | 2004-08-25 | Novartis AG | Sels comprenant un at1-recepteur antagoniste et un agent cardio-vasculaire |
US20030114389A1 (en) * | 2001-11-13 | 2003-06-19 | Webb Randy Lee | Combination of organic compounds |
RU2316318C2 (ru) * | 2002-05-17 | 2008-02-10 | Новартис Аг | Фармацевтическая композиция, включающая ингибитор ренина, блокатор кальциевых каналов и диуретик |
GB0212410D0 (en) * | 2002-05-29 | 2002-07-10 | Novartis Ag | Organic compounds |
GB0212412D0 (en) * | 2002-05-29 | 2002-07-10 | Novartis Ag | Combination of organic compounds |
US20030229007A1 (en) * | 2002-05-30 | 2003-12-11 | Roberto Levi | Form of human renin and its use as a target in treatments for cardiac ischemia and arrhythmia |
WO2004002957A1 (fr) | 2002-06-27 | 2004-01-08 | Actelion Pharmaceuticals Ltd | Nouveaux derives de tetrahydropyridine en tant qu'inhibiteurs de renine |
WO2004002549A1 (fr) * | 2002-06-28 | 2004-01-08 | Novartis Ag | Utilisation de composes organiques |
WO2004100871A2 (fr) * | 2003-05-09 | 2004-11-25 | Pharmacia Corporation | Combinaison d'un antagoniste du recepteur de l'aldosterone et d'un inhibiteur de renine |
JP2007504136A (ja) * | 2003-08-28 | 2007-03-01 | ニトロメッド インコーポレーティッド | ニトロソ化およびニトロシル化利尿化合物、組成物、ならびに使用方法 |
CA2547551A1 (fr) * | 2003-12-05 | 2005-06-16 | Actelion Pharmaceuticals Ltd | Derives de diazabicyclononene et de tetrahydropyridine comprenant une nouvelle chaine laterale |
BRPI0507030A (pt) * | 2004-01-22 | 2007-06-05 | Novartis Ag | combinação de compostos orgánicos |
AR047880A1 (es) * | 2004-02-17 | 2006-03-01 | Novartis Ag | COMBINACIoN DE UN INHIBIDOR DE RENINA Y DIURÉTICOS |
-
2005
- 2005-03-16 EP EP05716127A patent/EP1729749A2/fr not_active Ceased
- 2005-03-16 US US10/592,973 patent/US20080161321A1/en not_active Abandoned
- 2005-03-16 KR KR1020067018948A patent/KR20070006774A/ko not_active Application Discontinuation
- 2005-03-16 RU RU2006136091/15A patent/RU2426532C2/ru not_active IP Right Cessation
- 2005-03-16 SG SG200904145-0A patent/SG153831A1/en unknown
- 2005-03-16 NZ NZ549535A patent/NZ549535A/en not_active IP Right Cessation
- 2005-03-16 JP JP2007503285A patent/JP2007529459A/ja not_active Withdrawn
- 2005-03-16 CA CA002558020A patent/CA2558020A1/fr not_active Abandoned
- 2005-03-16 WO PCT/EP2005/002809 patent/WO2005089731A2/fr active Application Filing
- 2005-03-16 BR BRPI0508880-1A patent/BRPI0508880A/pt not_active IP Right Cessation
- 2005-03-16 AU AU2005224014A patent/AU2005224014B9/en not_active Ceased
- 2005-03-16 TW TW094108050A patent/TW200605867A/zh unknown
- 2005-03-16 NZ NZ586285A patent/NZ586285A/en not_active IP Right Cessation
- 2005-03-16 EP EP08158711A patent/EP1977741A3/fr not_active Withdrawn
-
2006
- 2006-08-31 IL IL177831A patent/IL177831A0/en unknown
- 2006-10-13 MA MA29389A patent/MA28535B1/fr unknown
- 2006-10-16 NO NO20064672A patent/NO20064672L/no not_active Application Discontinuation
-
2009
- 2009-09-28 AU AU2009222444A patent/AU2009222444A1/en not_active Abandoned
-
2010
- 2010-12-01 RU RU2010149052/15A patent/RU2010149052A/ru not_active Application Discontinuation
- 2010-12-13 IL IL209964A patent/IL209964A0/en unknown
-
2011
- 2011-04-25 JP JP2011097214A patent/JP2011178799A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
BRPI0508880A (pt) | 2007-09-04 |
US20080161321A1 (en) | 2008-07-03 |
TW200605867A (en) | 2006-02-16 |
RU2426532C2 (ru) | 2011-08-20 |
KR20070006774A (ko) | 2007-01-11 |
NZ586285A (en) | 2011-12-22 |
JP2011178799A (ja) | 2011-09-15 |
EP1977741A3 (fr) | 2009-10-14 |
RU2010149052A (ru) | 2012-06-10 |
SG153831A1 (en) | 2009-07-29 |
CA2558020A1 (fr) | 2005-09-29 |
AU2005224014A1 (en) | 2005-09-29 |
EP1977741A2 (fr) | 2008-10-08 |
WO2005089731A3 (fr) | 2006-05-11 |
RU2006136091A (ru) | 2008-04-27 |
IL209964A0 (en) | 2011-02-28 |
WO2005089731A2 (fr) | 2005-09-29 |
EP1729749A2 (fr) | 2006-12-13 |
NZ549535A (en) | 2010-11-26 |
AU2005224014B9 (en) | 2009-08-27 |
IL177831A0 (en) | 2006-12-31 |
NO20064672L (no) | 2006-12-14 |
AU2005224014B2 (en) | 2009-07-16 |
AU2009222444A1 (en) | 2009-10-15 |
JP2007529459A (ja) | 2007-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA28535B1 (fr) | Utilisation de composes organiques | |
MA29033B1 (fr) | Composes organiques | |
MA28490B1 (fr) | Formulations galeniques de composes organiques | |
DE602005009017D1 (de) | Substituierte n-sulfonylaminobenzyl-2-phenoxyacetamidverbindungen | |
IS8470A (is) | Notkun lífrænna efnasambanda | |
NO20070299L (no) | Novel heterocyclic compounds | |
AT500473B8 (de) | Inkubator | |
ATE384719T1 (de) | Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen | |
SE0402103D0 (sv) | Novel compounds | |
UA10953S (uk) | Комплект етикеток | |
UA9909S (uk) | Комплект етикеток | |
UA10527S (uk) | Комплект етикеток | |
UA10481S (uk) | Комплект етикеток | |
UA11076S (uk) | Комплект етикеток | |
UA11062S (uk) | Комплект етикеток | |
UA10641S (uk) | Набір етикеток | |
UA8735S (uk) | Комплект етикеток | |
UA11250S (uk) | Комплект етикеток | |
UA10374S (uk) | Розподільник перепускний | |
UA12382S (uk) | Комплект етикеток | |
UA13674S (uk) | Комплект етикеток | |
UA12903S (uk) | Комплект етикеток | |
UA12074S (uk) | Комплект етикеток | |
UA11690S (uk) | Комплект етикеток | |
UA12404S (uk) | Комплект етикеток |